Advantage of Scheduled Upfront Lenvatinib Administration Followed by Transarterial Chemoembolization Therapy Over Lenvatinib Monotherapy in Patients With Unresectable Intermediate‐Stage Hepatocellular Carcinoma: A Multicenter Cohort Study.
Saved in:
| Title: | Advantage of Scheduled Upfront Lenvatinib Administration Followed by Transarterial Chemoembolization Therapy Over Lenvatinib Monotherapy in Patients With Unresectable Intermediate‐Stage Hepatocellular Carcinoma: A Multicenter Cohort Study. |
|---|---|
| Authors: | Taniki, Nobuhito1 (AUTHOR) nobuhitotaniki@keio.jp, Ojiro, Keisuke1,2 (AUTHOR), Kasuga, Ryosuke1 (AUTHOR), Nakadai, Yukie1 (AUTHOR), Tabuchi, Takaya1 (AUTHOR), Chu, Po‐Sung1 (AUTHOR), Usui, Shingo1 (AUTHOR), Hoshi, Hitomi3 (AUTHOR), Kaneko, Fumihiko3 (AUTHOR), Yamaguchi, Akihiro4 (AUTHOR), Koizumi, Jun5 (AUTHOR), Ebinuma, Hirotoshi1,6 (AUTHOR), Tamura, Masashi7 (AUTHOR), Tsukada, Jitsuro7 (AUTHOR), Inoue, Masanori7,8 (AUTHOR), Nakatsuka, Seishi7 (AUTHOR), Hasegawa, Yasushi9 (AUTHOR), Abe, Yuta9 (AUTHOR), Kitago, Minoru9 (AUTHOR), Jinzaki, Masahiro7 (AUTHOR) |
| Source: | Cancer Medicine. Jan2026, Vol. 15 Issue 1, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 191105349 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Advantage of Scheduled Upfront Lenvatinib Administration Followed by Transarterial Chemoembolization Therapy Over Lenvatinib Monotherapy in Patients With Unresectable Intermediate‐Stage Hepatocellular Carcinoma: A Multicenter Cohort Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Taniki%2C+Nobuhito%22">Taniki, Nobuhito</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> nobuhitotaniki@keio.jp</i><br /><searchLink fieldCode="AR" term="%22Ojiro%2C+Keisuke%22">Ojiro, Keisuke</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kasuga%2C+Ryosuke%22">Kasuga, Ryosuke</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nakadai%2C+Yukie%22">Nakadai, Yukie</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tabuchi%2C+Takaya%22">Tabuchi, Takaya</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chu%2C+Po‐Sung%22">Chu, Po‐Sung</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Usui%2C+Shingo%22">Usui, Shingo</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hoshi%2C+Hitomi%22">Hoshi, Hitomi</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kaneko%2C+Fumihiko%22">Kaneko, Fumihiko</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yamaguchi%2C+Akihiro%22">Yamaguchi, Akihiro</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Koizumi%2C+Jun%22">Koizumi, Jun</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ebinuma%2C+Hirotoshi%22">Ebinuma, Hirotoshi</searchLink><relatesTo>1,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tamura%2C+Masashi%22">Tamura, Masashi</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tsukada%2C+Jitsuro%22">Tsukada, Jitsuro</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Inoue%2C+Masanori%22">Inoue, Masanori</searchLink><relatesTo>7,8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nakatsuka%2C+Seishi%22">Nakatsuka, Seishi</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hasegawa%2C+Yasushi%22">Hasegawa, Yasushi</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abe%2C+Yuta%22">Abe, Yuta</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kitago%2C+Minoru%22">Kitago, Minoru</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jinzaki%2C+Masahiro%22">Jinzaki, Masahiro</searchLink><relatesTo>7</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+Medicine%22">Cancer Medicine</searchLink>. Jan2026, Vol. 15 Issue 1, p1-9. 9p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=191105349 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cam4.71503 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 9 StartPage: 1 Titles: – TitleFull: Advantage of Scheduled Upfront Lenvatinib Administration Followed by Transarterial Chemoembolization Therapy Over Lenvatinib Monotherapy in Patients With Unresectable Intermediate‐Stage Hepatocellular Carcinoma: A Multicenter Cohort Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Taniki, Nobuhito – PersonEntity: Name: NameFull: Ojiro, Keisuke – PersonEntity: Name: NameFull: Kasuga, Ryosuke – PersonEntity: Name: NameFull: Nakadai, Yukie – PersonEntity: Name: NameFull: Tabuchi, Takaya – PersonEntity: Name: NameFull: Chu, Po‐Sung – PersonEntity: Name: NameFull: Usui, Shingo – PersonEntity: Name: NameFull: Hoshi, Hitomi – PersonEntity: Name: NameFull: Kaneko, Fumihiko – PersonEntity: Name: NameFull: Yamaguchi, Akihiro – PersonEntity: Name: NameFull: Koizumi, Jun – PersonEntity: Name: NameFull: Ebinuma, Hirotoshi – PersonEntity: Name: NameFull: Tamura, Masashi – PersonEntity: Name: NameFull: Tsukada, Jitsuro – PersonEntity: Name: NameFull: Inoue, Masanori – PersonEntity: Name: NameFull: Nakatsuka, Seishi – PersonEntity: Name: NameFull: Hasegawa, Yasushi – PersonEntity: Name: NameFull: Abe, Yuta – PersonEntity: Name: NameFull: Kitago, Minoru – PersonEntity: Name: NameFull: Jinzaki, Masahiro IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: Jan2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 20457634 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Cancer Medicine Type: main |
| ResultId | 1 |